| Product Code: ETC7536768 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Antimicrobial Resistance Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 India Antimicrobial Resistance Market - Industry Life Cycle |
3.4 India Antimicrobial Resistance Market - Porter's Five Forces |
3.5 India Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 India Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 India Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 India Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 India Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in India |
4.2.2 Growing awareness about the importance of antimicrobial resistance |
4.2.3 Rise in government initiatives and regulations to combat antimicrobial resistance |
4.3 Market Restraints |
4.3.1 Limited access to proper healthcare facilities in rural areas |
4.3.2 Lack of stringent enforcement of regulations regarding antimicrobial use |
4.3.3 Misuse and overuse of antibiotics leading to resistance |
5 India Antimicrobial Resistance Market Trends |
6 India Antimicrobial Resistance Market, By Types |
6.1 India Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 India Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 India Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 India Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 India Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 India Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 India Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 India Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 India Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 India Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 India Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 India Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 India Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 India Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 India Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 India Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 India Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 India Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 India Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 India Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 India Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 India Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 India Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 India Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 India Antimicrobial Resistance Market Export to Major Countries |
7.2 India Antimicrobial Resistance Market Imports from Major Countries |
8 India Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage of healthcare facilities following antimicrobial stewardship protocols |
8.2 Number of educational campaigns conducted on antimicrobial resistance awareness |
8.3 Rate of adoption of alternative treatments to antibiotics |
9 India Antimicrobial Resistance Market - Opportunity Assessment |
9.1 India Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 India Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 India Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 India Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 India Antimicrobial Resistance Market - Competitive Landscape |
10.1 India Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 India Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here